Expanded cord blood cells show promise in speeding recovery for blood cancer patients
Disease control
Completed
This study tested a new cord blood product called NiCord, which is grown in a lab to have more stem cells, against standard cord blood transplants for people with blood cancers like leukemia and lymphoma. The goal was to see if NiCord helps the body rebuild its blood and immune s…
Phase: PHASE3 • Sponsor: Gamida Cell ltd • Aim: Disease control
Last updated May 15, 2026 11:53 UTC